# SODIUM NITROPRUSSIDE
> **ANDA215846** · Abbreviated New Drug Application (Generic) · Sponsor: SLATE RUN PHARMA · Approved 2022-08-26
## Drug
- **FDA Application Number:** ANDA215846
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM NITROPRUSSIDE
- **Generic name:** SODIUM NITROPRUSSIDE IN 0.9% SODIUM CHLORIDE
- **Active ingredients:** SODIUM NITROPRUSSIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** SLATE RUN PHARMA
- **Manufacturer:** Slate Run Pharmaceuticals, LLC
- **First approval:** 2022-08-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215846)
---
*MORVS · CC0 1.0*